Pharmacological inhibition of PERK prevented reductions in Nav1.5, Kv4.3, and Kv1.5 channel proteins while resulting in shortened QTc intervals, fewer episodes of VAs, reduced mortality rates, and diminished overall arrhythmia risk in MI mouse models [52]. Here, SCN5A is linked to Arrhythmia.